ACC 22 Late-breaker Discussion: The SODIUM-HF Trial | with Dr Harriette Van Spall

Подробнее о видео

Watch the full video on Radcliffe Cardiology here:

In this in-depth conversational interview, Late-breaker host Dr Harriette Van Spall (McMaster University, CA) meets PI, Dr Justin A. Ezekowitz (University of Alberta, Edmonton, AB, CA) to discuss the SODIUM-HF trial. The aim of the trial was to evaluate the effects of a low-sodium diet, compared to usual care, in patients with heart failure.

Presented first at ACC 2022, the trial showed that reducing sodium intake did not reduce clinical events but there was a modest benefit on quality of life as measured by the KCCQ, and in NYHA class.

Recorded remotely from Edmonton and Hamilton, 2022.

Editor: Mirjam Boros

This content is intended for healthcare professionals only.

Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.